Executive Activity and Q1 Updates Provide Mixed Signals for Nexgel Inc.
The recent sale of shares by NEXGEL, INC. CEO Adam R. Levy, combined with the company's Q1 2026 financial results and positive developments in its product pipeline, presents a complex picture for investors. While Mr. Levy sold stock near the company's 52-week low, Nexgel reported a revenue decrease of 5.7% year-over-year. Conversely, the firm noted…